| 000 | 01697 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517145839.0 | ||
| 264 | 0 | _c20180418 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a2163-8306 | ||
| 024 | 7 |
_a10.1002/psp4.12195 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchindler, E | |
| 245 | 0 | 0 |
_aPharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal Tumors. _h[electronic resource] |
| 260 |
_bCPT: pharmacometrics & systems pharmacology _c07 2017 |
||
| 300 |
_a449-457 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Stromal Tumors _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xtherapeutic use |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aKrishnan, S M | |
| 700 | 1 | _aMathijssen, Rhj | |
| 700 | 1 | _aRuggiero, A | |
| 700 | 1 | _aSchiavon, G | |
| 700 | 1 | _aFriberg, L E | |
| 773 | 0 |
_tCPT: pharmacometrics & systems pharmacology _gvol. 6 _gno. 7 _gp. 449-457 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/psp4.12195 _zAvailable from publisher's website |
| 999 |
_c27051857 _d27051857 |
||